And unfortunately this is an example where we are restricting access in a way that will likely lead to more severe illness and less health and well-being among our fellow Pennsylvanians. Since 2023, the state has paid for Medicaid patients weight-loss treatment with these drugs, known as GLP-1s
Researchers are still uncovering aspects of GLP-1s, and the extent of their effects on muscle mass is still unclear, according to a lab scientist on Sermo
Contact us if youd like to request reuse of a visual asset
Regulators are concerned that making the medicine widely available could lead to: Misdiagnosis: Patients self-treating a different, underlying condition
The peptides dual mechanism of simultaneously enhancing lipolysis and inhibiting lipogenesis creates optimal metabolic conditions for fat loss while preserving lean tissue
If you are on a higher dose, say 7.5mg or above , the smaller injection volume means less liquid under the skin